<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0013">
 <label>13</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Reeta</surname>
   </name>
   <name>
    <surname>Baek</surname>
    <given-names>SC</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lee</surname>
    <given-names>JP</given-names>
   </name>, 
   <name name-style="western">
    <surname>Rangarajan</surname>
    <given-names>TM</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Ethyl acetohydroxamate incorporated chalcones: Unveiling a novel class of chalcones for multitarget monoamine oxidase-B inhibitors against Alzheimer’s disease</article-title>. 
  <source>CNS Neurol Disord Drug Targets</source>
  <year>2019</year>;
  <volume>18</volume>:
  <fpage>643</fpage>–
  <lpage>54</lpage>.
  <pub-id pub-id-type="pmid">31550216</pub-id>
 </mixed-citation>
</ref>
